LifeStance Health Group's biggest risks in the FY2024 10-K
- LifeStance Health's risks are dominated by third-party payor dependence, clinician retention and recruitment, and complex healthcare regulations.
The risks most specific to LifeStance Health Group
- Risks Related to Our Business and Our Industry
If reimbursement rates paid by third-party payors are reduced or if third-party payors otherwise restrain our ability to obtain or deliver care to patients, our business could be harmed
During 2024, 96% of patients were insured, making business vulnerable if commercial third-party payors reduce reimbursement rates or drop coverage.
- Risks Related to Our Business and Our Industry
We face competition for experienced clinicians that may increase labor costs and reduce profitability if we are unable to retain clinicians
Inability to retain and attract qualified clinicians could increase labor costs and reduce profitability.
- Risks Related to Our Business and Our Industry
The federal government and several states have enacted laws restricting the amount out-of-network providers of services can charge and recover for such services
The No Surprises Act restricts out-of-network charges and introduces dispute resolution processes for healthcare consumers.
- Risks Related to Our Business and Our Industry
We may receive reimbursement for virtual services that is less than for comparable in-person services, which would negatively impact revenue and results of operations
Fewer than half of states require payment parity for telehealth, risking lower reimbursement for virtual services.
- Risks Related to Healthcare and Data Privacy Regulation
We are dependent on our relationships with supported practices, which we do not own, to provide healthcare services, and our business would be harmed if those relationships were disrupted or if our arrangements with these entities became subject to legal challenges
Corporate practice of medicine prohibitions in certain states could disrupt relationships with supported practices.
- Risks Related to Indebtedness
Our existing indebtedness could adversely affect our business and growth prospects
The company had $290.0 million in principal amount outstanding under its 2024 Credit Agreement as of December 31, 2024.
All 54 risk factors
Headings as the filing states them, in filing order.
Risks Related to Our Business and Our Industry
- 01If reimbursement rates paid by third-party payors are reduced or if third-party payors otherwise restrain our ability to obtain or deliver care to patients, our business could be harmed
- 02We may not grow at the rates we historically have achieved or at all, even if our key metrics may imply future growth, including if we are unable to successfully execute on our growth initiatives and business strategies
- 03If we fail to manage our growth effectively, our expenses could increase more than expected, our revenue may not increase proportionally or at all, and we may be unable to execute on our business strategy
- 04We face competition for experienced clinicians that may increase labor costs and reduce profitability if we are unable to retain clinicians
- 05Our growth depends on our ability to recruit, acquire and retain clinicians
- 06operations, and we may have difficulty integrating any such acquisitions successfully or realizing the anticipated benefits therefrom
- 07Our inability to successfully integrate or realize the anticipated benefits from acquisitions could adversely affect our business, results of operations and financial condition
- 08We operate in a competitive industry, and if we are not able to compete effectively, our business and financial performance would be harmed
- 09quality to ours. Competition from specialized providers, medical practices, retailers, digital health companies and other parties could negatively impact our revenue and market share
- 10Even if the markets in which we compete achieve our forecasted growth, our business could fail to grow at similar rates, if at all
- 11The federal government and several states have enacted laws restricting the amount out-of-network providers of services can charge and recover for such services
- 12Financial pressures on patients, as well as economic conditions, may adversely affect our patient volume
- 13We may receive reimbursement for virtual services that is less than for comparable in-person services, which would negatively impact revenue and results of operations
- 14Failure to timely or accurately bill for our services could have a negative impact on our patient service revenue, credit losses and cash flow
- 15We face inspections, reviews, audits and investigations under our commercial payor contracts and pursuant to federal and state programs. These audits could have adverse findings that may negatively affect our business, including our results of operations, liquidity, financial condition and reputation
- 16loss of certain rights under, or termination of, our contracts with commercial payors
- 17We are dependent on credentialing our clinicians under our insurance contracts at the time of hire
- 18Our business depends on our ability to effectively invest in, implement improvements to and properly maintain the uninterrupted operation and data integrity of our information technology and other business systems
- 19If we cannot license rights to use technologies on reasonable terms, our ability to provide digital services, including virtual visits, and develop our technology platform would be inhibited
- 20We lease all of our centers and may experience risks relating to lease terminations, lease expense escalators, lease extensions and special charges
- 21abandonment of the space, use of the space of a purpose not permitted under the lease, failure to maintain the premises in good condition, or creation and maintenance of a nuisance. If a lease agreement is terminated, we may not be able to enter into a new lease agreement on similar or better terms or at all
- 22We depend on our executive team, and the loss of one or more of our executive officers or key employees or an inability to attract and retain highly skilled employees could harm our business
- 23Litigation, including in connection with commercial disputes or employment claims, against us could be costly and time-consuming to defend
- 24Natural or man-made disasters and other similar events may significantly disrupt our business and negatively impact our business, financial condition and results of operations
- 25We, our clinicians and supported practices may become subject to medical liability claims, which could cause us to incur significant expenses and may require us to pay significant damages if not covered by insurance
- 26If we fail to cost-effectively develop widespread brand awareness and maintain our reputation, or if we fail to achieve and maintain market acceptance for our mental health services, our business could suffer
- 27If our trademarks and trade names are not adequately protected, we may not be able to build name recognition in our markets of interest and our competitive position may be harmed
- 28Our quarterly results may fluctuate significantly, which could adversely impact the value of our common stock
- 29Our failure to raise additional capital or generate cash flows necessary to execute our growth strategy in the future could reduce our ability to compete successfully and harm our results of operations
- 30pursue acquisition opportunities
Risks Related to Healthcare and Data Privacy Regulation
- 31state and federal statutes and regulations that govern workplace health and safety
- 32Regulations related to healthcare are evolving and our ability to provide virtual service across regions could be hampered
- 33We are dependent on our relationships with supported practices, which we do not own, to provide healthcare services, and our business would be harmed if those relationships were disrupted or if our arrangements with these entities became subject to legal challenges
- 34The impact on us of healthcare reform legislation and other changes in the healthcare industry and in healthcare spending, including as a result of the 2024 elections, is currently unknown, but may harm our business
- 35Numerous federal and state laws and regulations govern collection, dissemination, use and confidentiality of personally identifiable health information, including state privacy and confidentiality laws (including state laws requiring notification of data breaches) and HIPAA
- 36Laws regulating scope of clinician practices and supervision requirements may constrain our ability to grow and meet patient needs
- 37Regulations related to telehealth are still evolving. To the extent regulations revert to their pre-COVID state, our ability to provide or be reimbursed for certain telehealth services could be impaired
Risks Related to Indebtedness
- 38Our existing indebtedness could adversely affect our business and growth prospects
- 39making us more vulnerable in the event of a downturn in our business
- 40We may not be able to generate sufficient cash flow to service all of our indebtedness, and may be forced to take other actions to satisfy our obligations under such indebtedness, which may not be successful
- 41The terms of the 2024 Credit Agreement restrict our current and future operations, particularly our ability to respond to changes or to take certain actions
- 42You should read the discussion under the heading “Management's Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources” for further information about these covenants
- 43unable to compete effectively or to take advantage of new business opportunities
Risks Related to Our Common Stock
- 44Our Principal Stockholders control us, and their interests may conflict with ours or yours
- 45We are a “controlled company” within the meaning of the rules of Nasdaq and, as a result, we qualify for exemptions from certain corporate governance requirements. You will not have the same protections as those afforded to stockholders of companies that are subject to such governance requirements
- 46We have in the past and will continue to incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to compliance with our public company responsibilities and corporate governance practices
- 47If we fail to maintain effective internal control over financial reporting and effective disclosure controls and procedures, we may not be able to accurately report our financial results in a timely manner or prevent fraud, which may adversely affect investor confidence in our company
- 48Provisions of our corporate governance documents could make an acquisition of our Company more difficult and may prevent attempts by our stockholders to replace or remove our current management, even if beneficial to our stockholders
- 49any other action asserting a claim against us that is governed by the internal affairs doctrine (each, a “Covered Proceeding”)
- 50Our amended and restated certificate of incorporation contains a provision renouncing our interest and expectancy in certain corporate opportunities, which could adversely impact our business
- 51Our stock price is volatile, and the value of our common stock may decline
- 52general economic conditions and trends
- 53We do not expect to pay any dividends for the foreseeable future
- 54If securities or industry analysts publish unfavorable or inaccurate research about our business, our common stock price and trading volume could decline
Other LifeStance Health Group 10-Ks
- FY2025 10-K risk factors56 risks4 new2 dropped7 reworded
LifeStance Health highlights growing risks from government healthcare policy changes, AI-driven competition, and stricter telehealth regulations.
Filed Feb 25, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.